Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

J. P. Rissing; C. Newman; W. L. Moore

doi:10.1128/AAC.14.4.636

Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

J. P. Rissing, C. Newman, W. L. Moore

Infectious Disease

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

Original language	English (US)
Pages (from-to)	636-638
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	14
Issue number	4
DOIs	https://doi.org/10.1128/AAC.14.4.636
State	Published - 1978

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.14.4.636

Cite this

@article{4e700fd6411343d6817d682ff1316b51,

title = "Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole",

abstract = "Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.",

author = "Rissing, {J. P.} and C. Newman and Moore, {W. L.}",

year = "1978",

doi = "10.1128/AAC.14.4.636",

language = "English (US)",

volume = "14",

pages = "636--638",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

AU - Rissing, J. P.

AU - Newman, C.

AU - Moore, W. L.

PY - 1978

Y1 - 1978

N2 - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

AB - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

UR - http://www.scopus.com/inward/record.url?scp=0018084560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018084560&partnerID=8YFLogxK

U2 - 10.1128/AAC.14.4.636

DO - 10.1128/AAC.14.4.636

M3 - Article

C2 - 214030

AN - SCOPUS:0018084560

VL - 14

SP - 636

EP - 638

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -

Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this